Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ben Hitchinson

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Advances in Experimental Medicine and Biology|November 11, 2019
Advances in NMR Methods to Identify Allosteric Sites and Allosteric LigandsHazem Abdelkarim, Ben Hitchinson, Avik Banerjee, et al.
Plos One|May 19, 2020
NMR resonance assignment and structure prediction of the C-terminal domain of the microtubule end-binding protein 3Hazem Abdelkarim, Ben Hitchinson, Xinyan Qu, et al.
Molecular Cancer Therapeutics|March 31, 2019
Vemurafenib Inhibits Active PTK6 in <i>PTEN</i>-null Prostate Tumor CellsDarren J Wozniak, Ben Hitchinson, Milica B Gilic, et al.
Oncology Reports|May 23, 2015
Apoptosis inhibitor TRIAP1 is a novel effector of drug resistanceCaroline Adams, Giulia Cazzanelli, Sabeena Rasul, et al.
The Journal of Biological Chemistry|February 26, 2015
Mechanisms of membrane binding of small GTPase K-Ras4B farnesylated hypervariable regionHyunbum Jang, Sherwin J Abraham, Tanmay S Chavan, et al.
Cell Death & Disease|January 26, 2018
Honokiol is a FOXM1 antagonistMarianna Halasi, Ben Hitchinson, Binal N Shah, et al.
Science Signaling|October 18, 2018
Biased antagonism of CXCR4 avoids antagonist toleranceBen Hitchinson, Jonathan M Eby, Xianlong Gao, et al.
The Journal of Allergy and Clinical Immunology|May 21, 2018
Novel peptide nanoparticle-biased antagonist of CCR3 blocks eosinophil recruitment and airway hyperresponsivenessMilica Grozdanovic, Kimberly G Laffey, Hazem Abdelkarim, et al.
Cell Reports. Medicine|October 5, 2023
End binding-3 inhibitor activates regenerative program in age-related macular degenerationQuinn Lee, Wan Ching Chan, Xinyan Qu, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Advances in Experimental Medicine and Biology|November 11, 2019
Advances in NMR Methods to Identify Allosteric Sites and Allosteric LigandsHazem Abdelkarim, Ben Hitchinson, Avik Banerjee, et al.
Plos One|May 19, 2020
NMR resonance assignment and structure prediction of the C-terminal domain of the microtubule end-binding protein 3Hazem Abdelkarim, Ben Hitchinson, Xinyan Qu, et al.
Molecular Cancer Therapeutics|March 31, 2019
Vemurafenib Inhibits Active PTK6 in <i>PTEN</i>-null Prostate Tumor CellsDarren J Wozniak, Ben Hitchinson, Milica B Gilic, et al.
Oncology Reports|May 23, 2015
Apoptosis inhibitor TRIAP1 is a novel effector of drug resistanceCaroline Adams, Giulia Cazzanelli, Sabeena Rasul, et al.
The Journal of Biological Chemistry|February 26, 2015
Mechanisms of membrane binding of small GTPase K-Ras4B farnesylated hypervariable regionHyunbum Jang, Sherwin J Abraham, Tanmay S Chavan, et al.
Cell Death & Disease|January 26, 2018
Honokiol is a FOXM1 antagonistMarianna Halasi, Ben Hitchinson, Binal N Shah, et al.
Science Signaling|October 18, 2018
Biased antagonism of CXCR4 avoids antagonist toleranceBen Hitchinson, Jonathan M Eby, Xianlong Gao, et al.
The Journal of Allergy and Clinical Immunology|May 21, 2018
Novel peptide nanoparticle-biased antagonist of CCR3 blocks eosinophil recruitment and airway hyperresponsivenessMilica Grozdanovic, Kimberly G Laffey, Hazem Abdelkarim, et al.
Cell Reports. Medicine|October 5, 2023
End binding-3 inhibitor activates regenerative program in age-related macular degenerationQuinn Lee, Wan Ching Chan, Xinyan Qu, et al.
Pageof 1